Dang, Q.M.; Watanabe, R.; Shiomi, M.; Fukumoto, K.; Nobashi, T.W.; Okano, T.; Yamada, S.; Hashimoto, M.
Rheumatic Immune-Related Adverse Events due to Immune Checkpoint Inhibitors—A 2023 Update. Int. J. Mol. Sci. 2023, 24, 5643.
https://doi.org/10.3390/ijms24065643
AMA Style
Dang QM, Watanabe R, Shiomi M, Fukumoto K, Nobashi TW, Okano T, Yamada S, Hashimoto M.
Rheumatic Immune-Related Adverse Events due to Immune Checkpoint Inhibitors—A 2023 Update. International Journal of Molecular Sciences. 2023; 24(6):5643.
https://doi.org/10.3390/ijms24065643
Chicago/Turabian Style
Dang, Quang Minh, Ryu Watanabe, Mayu Shiomi, Kazuo Fukumoto, Tomomi W. Nobashi, Tadashi Okano, Shinsuke Yamada, and Motomu Hashimoto.
2023. "Rheumatic Immune-Related Adverse Events due to Immune Checkpoint Inhibitors—A 2023 Update" International Journal of Molecular Sciences 24, no. 6: 5643.
https://doi.org/10.3390/ijms24065643
APA Style
Dang, Q. M., Watanabe, R., Shiomi, M., Fukumoto, K., Nobashi, T. W., Okano, T., Yamada, S., & Hashimoto, M.
(2023). Rheumatic Immune-Related Adverse Events due to Immune Checkpoint Inhibitors—A 2023 Update. International Journal of Molecular Sciences, 24(6), 5643.
https://doi.org/10.3390/ijms24065643